218 related articles for article (PubMed ID: 36177738)
21. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.
Stein L; Kircik L; Fowler J; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Liu H; Jacovella J
J Drugs Dermatol; 2014 Mar; 13(3):316-23. PubMed ID: 24595578
[TBL] [Abstract][Full Text] [Related]
22. A novel moisturizer with high sun protection factor improves cutaneous barrier function and the visible appearance of rosacea-prone skin.
Baldwin H; Santoro F; Lachmann N; Teissedre S
J Cosmet Dermatol; 2019 Dec; 18(6):1686-1692. PubMed ID: 30803131
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of low molecular weight hyaluronic acid sodium salt 0.2% cream in rosacea.
Schlesinger TE; Powell CR
J Drugs Dermatol; 2013 Jun; 12(6):664-7. PubMed ID: 23839183
[TBL] [Abstract][Full Text] [Related]
24. The efficacy and safety of permethrin 2.5% with tea tree oil gel on rosacea treatment: A double-blind, controlled clinical trial.
Ebneyamin E; Mansouri P; Rajabi M; Qomi M; Asgharian R; Azizian Z
J Cosmet Dermatol; 2020 Jun; 19(6):1426-1431. PubMed ID: 31613050
[TBL] [Abstract][Full Text] [Related]
25. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption.
Chu CY
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975
[TBL] [Abstract][Full Text] [Related]
26. A Split-Face Study Assessing the Clinical Benefit, Tolerability and Subject Satisfaction of a Dermocosmetic in Subjects with Rosacea Associated with Erythema and Sensitive Skin.
Berardesca E; Bonfigli A; Cribier B; Flament F; Vicic M; Kerob D; Tan J
Clin Cosmet Investig Dermatol; 2020; 13():751-758. PubMed ID: 33116738
[TBL] [Abstract][Full Text] [Related]
27. Open-label study assessing the efficacy and tolerability of topical skin care and sun protection alone and in combination with intense pulsed light therapy.
Deaver Peterson J; Katz TM
J Cosmet Dermatol; 2019 Dec; 18(6):1758-1764. PubMed ID: 31017734
[TBL] [Abstract][Full Text] [Related]
28. Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study.
Gold LS; Papp K; Lynde C; Lain E; Gooderham M; Johnson S; Kerrouche N
J Drugs Dermatol; 2017 Sep; 16(9):909-916. PubMed ID: 28915286
[TBL] [Abstract][Full Text] [Related]
29. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial.
Kircik LH; DuBois J; Draelos ZD; Werschler P; Grande K; Cook-Bolden FE; Weng E; Berk DR; Ahluwalia G
J Drugs Dermatol; 2018 Jan; 17(1):97-105. PubMed ID: 29320594
[TBL] [Abstract][Full Text] [Related]
30. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
Karabulut AA; Izol Serel B; Eksioglu HM
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
[TBL] [Abstract][Full Text] [Related]
31. Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study.
Koçak M; Yağli S; Vahapoğlu G; Ekşioğlu M
Dermatology; 2002; 205(3):265-70. PubMed ID: 12399675
[TBL] [Abstract][Full Text] [Related]
32. Facial flushing and erythema of rosacea improved by carvedilol.
Seo BH; Kim DH; Suh HS; Choi YS
Dermatol Ther; 2020 Nov; 33(6):e14520. PubMed ID: 33174351
[TBL] [Abstract][Full Text] [Related]
33. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea.
Maddin S
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):961-5. PubMed ID: 10365928
[TBL] [Abstract][Full Text] [Related]
34. [PATHOGENETIC FEATURES AND METHODS FOR TREATMENT OF VARIOUS FORMS OF ROSACEA].
Tsiskarishvili T; Katsitadze A; Tsiskarishvili NV; Tsiskarishvili NI; Chitanava L
Georgian Med News; 2019 Apr; (289):116-120. PubMed ID: 31215891
[TBL] [Abstract][Full Text] [Related]
35. Clinical and noninvasive instrumental evaluation of the efficacy of a nonsteroidal anti-inflammatory 8-beta glycyrrhetinic acid cream for the treatment of erythema in rosacea.
Cameli N; Mariano M; Zanniello R; Berardesca E
Dermatol Ther; 2020 Nov; 33(6):e14224. PubMed ID: 32833275
[TBL] [Abstract][Full Text] [Related]
36. Topical Oxymetazoline Cream 1.0% for Persistent Facial Erythema Associated With Rosacea: Pooled Analysis of the Two Phase 3, 29-Day, Randomized, Controlled REVEAL Trials.
Stein-Gold L; Kircik L; Draelos ZD; Werschler P; DuBois J; Lain E; Baumann L; Goldberg D; Kaufman J; Tanghetti E; Ahluwalia G; Alvandi N; Weng E; Berk D
J Drugs Dermatol; 2018 Nov; 17(11):1201-1208. PubMed ID: 30500142
[TBL] [Abstract][Full Text] [Related]
37. S2k guideline: Rosacea.
Clanner-Engelshofen BM; Bernhard D; Dargatz S; Flaig MJ; Gieler U; Kinberger M; Klövekorn W; Kuna AC; Läuchli S; Lehmann P; Nast A; Pleyer U; Schaller M; Schöfer H; Steinhoff M; Schwennesen T; Werner RN; Zierhut M; Reinholz M
J Dtsch Dermatol Ges; 2022 Aug; 20(8):1147-1165. PubMed ID: 35929658
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a novel very high sun-protection-factor moisturizer in adults with rosacea-prone sensitive skin.
Grivet-Seyve M; Santoro F; Lachmann N
Clin Cosmet Investig Dermatol; 2017; 10():211-219. PubMed ID: 28652793
[TBL] [Abstract][Full Text] [Related]
39. Real-life experience on effectiveness and tolerability of topical ivermectin in papulopustular rosacea and antiparasitic effect on Demodex mites.
Trave I; Merlo G; Cozzani E; Parodi A
Dermatol Ther; 2019 Nov; 32(6):e13093. PubMed ID: 31579993
[TBL] [Abstract][Full Text] [Related]
40. Ivermectin 1% cream for rosacea.
Gupta G; Daigle D; Gupta AK; Gold LS
Skin Therapy Lett; 2015; 20(4):9-11. PubMed ID: 26382711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
